Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy

被引:1
|
作者
Peng, Qianyu [1 ]
Xu, Lili [1 ]
Zhang, Gumuyang [1 ]
Zhang, Daming [1 ]
Zhang, Jiahui [1 ]
Zhang, Xiaoxiao [1 ]
Bai, Xin [1 ]
Chen, Li [1 ]
Jin, Zhengyu [1 ,2 ]
Sun, Hao [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Radiol,State Key Lab Complex Severe & Rare Di, Shuaifuyuan 1,Wangfujing St, Beijing 100730, Peoples R China
[2] Natl Ctr Qual Control Radiol, Shuaifuyuan 1,Wangfujing St, Beijing 100730, Peoples R China
关键词
Magnetic resonance imaging; Prostate imaging-reporting and data system; Radical prostatectomy; Positive surgical margins; Pathological outcomes; CANCER; RISK; MEN;
D O I
10.1186/s40644-023-00619-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To assess the effect of preoperative MRI with standardized Prostate Imaging-Reporting and Data System (PI-RADS) assessment on pathological outcomes in prostate cancer (PCa) patients who underwent radical prostatectomy (RP). Patients and methods This retrospective cohort study included patients who had undergone prostate MRI and subsequent RP for PCa between January 2017 and December 2022. The patients were divided into the PI-RADS group and the non-PI-RADS group according to evaluation scheme of presurgery MRI. The preoperative characteristics and postoperative outcomes were retrieved and analyzed. The pathological outcomes included pathological T stage (pT2 vs. pT3-4) and positive surgical margins (PSMs). Patients were further stratified according to statistically significant preoperative variables to assess the difference in pathological outcomes. A propensity score matching based on the above preoperative characteristics was additionally performed. Results A total of 380 patients were included in this study, with 201 patients in the PI-RADS group and 179 in the non-PI-RADS group. The two groups had similar preoperative characteristics, except for clinical T stage (cT). As for pathological outcomes, the PI-RADS group showed a significantly lower percentage of pT3-4 (21.4% vs. 48.0%, p < 0.001), a lower percentage of PSMs (31.3% vs. 40.9%, p = 0.055), and a higher concordance between the cT and pT (79.1% vs. 64.8%, p = 0.003). The PI-RADS group also showed a lower proportion of pT3-4 (p < 0.001) in the cT1-2 subgroup and the cohort after propensity score matching. The PSM rate of cT3 patients was reduced by 39.2% in the PI-RADS group but without statistical significance (p = 0.089). Conclusions Preoperative MRI with standardized PI-RADS assessment could benefit the decision-making of patients by reducing the rate of pathologically confirmed non-organ-confined PCa after RP and slightly reducing the PSM rate compared with non-PI-RADS assessment.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The incidence of postoperative ileus in patients who underwent robotic assisted radical prostatectomy
    Ozdemir, Ahmet Tunc
    Altinova, Serkan
    Koyuncu, Hakan
    Serefoglu, Ege Can
    Cimen, Ibrahim Haci
    Balbay, Derya Mevlana
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2014, 67 (01) : 19 - 24
  • [42] THE IMPACT OF ANXIETY AND DEPRESSION ON FUNCTIONAL OUTCOME IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY
    Pompe, Raisa Sinaida
    Krueger, Alexander
    Karakiewicz, Pierre I.
    Mandel, Philipp
    Gild, Philipp
    Leyh-Bannurah, Sami-Ramzi
    Salomon, Georg
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    JOURNAL OF UROLOGY, 2017, 197 (04): : E985 - E985
  • [43] Correlation of Prostate Cancer PI-RADS v2 Assessment Categories with Gleason Pattern and Tumor Quantity in Whole Mount Radical Prostatectomy Specimens
    Hwang, Michael J.
    Weinreb, Jeffrey
    Humphrey, Peter
    Syed, Jamil
    Sprenkle, Preston
    Levi, Angelique
    MODERN PATHOLOGY, 2017, 30 : 232A - 232A
  • [44] FACTORS ASSOCIATED WITH THE DECREASE IN ORGASM INTENSITY IN PATIENTS WHO UNDERWENT TO RADICAL PROSTATECTOMY
    Gamberini, P.
    Nascimento, B.
    Barbosa Neto, C.
    Pedrenho, R.
    Goes, P.
    de Bessa Junior, J.
    Sphair, J.
    Nahas, W.
    Srougi, M.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S209 - S209
  • [45] Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions?
    Koparal, Murat Yavuz
    Soezen, Tevfik Sinan
    Karsiyakali, Nejdet
    Akdogan, Buelent
    oezen, Haluk
    Aslan, Gueven
    Tuerkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (05): : 410 - 415
  • [46] PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer
    Woo, Sungmin
    Kim, Sang Youn
    Lee, Joongyub
    Kim, Seung Hyup
    Cho, Jeong Yeon
    EUROPEAN RADIOLOGY, 2016, 26 (10) : 3580 - 3587
  • [47] PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer
    Sungmin Woo
    Sang Youn Kim
    Joongyub Lee
    Seung Hyup Kim
    Jeong Yeon Cho
    European Radiology, 2016, 26 : 3580 - 3587
  • [48] Association between preoperative serum total cholesterol level and biochemical recurrence in prostate cancer patients who underwent radical prostatectomy
    Ohno, Yoshio
    Ohori, Makoto
    Nakashima, Jun
    Okubo, Hidenori
    Satake, Naoya
    Hashimoto, Takeshi
    Tachibana, Masaaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (06) : 1073 - 1077
  • [49] Radical Prostatectomy Findings in Men with Grade Group 1 Cancer on Biopsy Significantly Differ Between Those with PI-RADS 4-5 and PI-RADS 3 Radiologic Lesions and are Worse in White Hispanic and Black Men
    Iakymenko, Oleksii
    Jorda, Merce
    Kryvenko, Oleksandr
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 601 - 602
  • [50] Radical Prostatectomy Findings in Men with Grade Group 1 Cancer on Biopsy Significantly Differ Between Those with PI-RADS 4-5 and PI-RADS 3 Radiologic Lesions and are Worse in White Hispanic and Black Men
    Iakymenko, Oleksii
    Jorda, Merce
    Kryvenko, Oleksandr
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 601 - 602